Investigation Overview
San Diego, April 2, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) was announced over potential securities laws violations by certain officers and directors at MAP Pharmaceuticals Inc. in connection with certain potentially false and misleading statements. The investigation by a law firm focuses on possibl...
You must register (for free) or login to view the entire investigation.